/5
0 avis
Early benefit with empagliflozin in heart failure with preserved ejection fraction: insights from the EMPEROR‐Preserved trial
Archive ouverte
Edité par CCSD ; European Society of Cardiology (Wiley) -
International audience
Consulter en ligne
Chargement des enrichissements...